GABRIEL J SERMON

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical DRAPER, UT NPI 1639299282

General Payments — all program years on this page

$1,689.50

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 96
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $332.22 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $332.2221

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $172.8711
Acerta Pharma LLC $63.224
Amgen Inc. $35.602
Boehringer Ingelheim Pharmaceuticals, Inc. $16.781
AIMMUNE THERAPEUTICS, INC. $15.701
PFIZER INC. $14.631
Novo Nordisk AS $13.421

By program year

Program yearAmountRecords
2021 $421.4827
2022 $411.7422
2023 $524.0626
2024 $332.2221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100614309 Novo Nordisk Inc $13.42 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105460090 AstraZeneca Pharmaceuticals LP $14.21 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105588546 AstraZeneca Pharmaceuticals LP $16.38 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105626143 AstraZeneca Pharmaceuticals LP $17.46 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105719806 AstraZeneca Pharmaceuticals LP $15.17 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174176 ABBVIE INC. $21.88 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174178 ABBVIE INC. $11.31 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174180 ABBVIE INC. $25.49 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174182 ABBVIE INC. $9.60 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174184 ABBVIE INC. $26.32 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174186 ABBVIE INC. $32.21 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174188 ABBVIE INC. $9.53 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174190 ABBVIE INC. $6.21 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174192 ABBVIE INC. $14.41 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174194 ABBVIE INC. $11.47 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108174196 ABBVIE INC. $4.44 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117680038 Amgen Inc. $13.92 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117680040 Amgen Inc. $21.68 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118090364 Boehringer Ingelheim Pharmaceuticals, Inc. $16.78 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131687430 PFIZER INC. $14.63 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146963723 AIMMUNE THERAPEUTICS, INC. $15.70 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.